16126710
Beschreibung
Mindmap von Tatiana Suarez, aktualisiert more than 1 year ago
|
Erstellt von Tatiana Suarez
vor mehr als 5 Jahre
|
|
The evolution of negotiations of
intangible assets apart from industrial
property protection in biotechnology
- STATE OF NEGOTIATIONS OF
INTAGIBLE ASSETS IN THE WORLD
- In 1990’s was due to a boom in the negotiations of
intangible assets
- Enterprise merging and acquisition,
using the IFRS3 [3] and FASB 141 [4]
standards as guidelines for their
valuation.
- The former standard points
out the following restrictions:
- Only acquired
intangibles are valued
- Goodwill is often not
identified
- Intangibles are
undervalued
- The increased value of the
intangible assets is not
acknowledged
- Only acquired
intangibles are valued
- The former standard points
out the following restrictions:
- Some examples of
negotiations of intangible
assets
- When Proctor and Gamble purchased Gillette in 63
billion dollars in 2005, the intangible assets were
valued in 55 billion dollars
- Walt Disney paid 7.5 billion
dollars for the Pixar digital
animation studio.
- In 2006, Google purchased
YouTube for 1.2 billion dollars,
which reached the headlines
of the brand stock exchange
- When Proctor and Gamble purchased Gillette in 63
billion dollars in 2005, the intangible assets were
valued in 55 billion dollars
- In 1990’s was due to a boom in the negotiations of
intangible assets
- THE INTANGIBLE STRENGTH OF THE
CUBAN BIOTECHONOLOGY INDUSTRY
- Modern biotechnology, which arose and was developed
through the 1970’s and 1980’s, has been normally
established as coming from industrialized countries.
- Novel products are
developed, which include
- The preventive vaccine against
Neisseria meningitidis type b, with
patents granted in several countries
- PPG, a unique product with
three patents granted
- The vaccine against Haemophilus
influenzae type b, the only commercial
vaccine obtained by chemical synthesis
- Heberprot-P®, a unique product with a
patent, with a demonstrated high
effectiveness in the treatment of diabetic
foot ulcers
- The preventive vaccine against
Neisseria meningitidis type b, with
patents granted in several countries
- been inspected by prestigious
regulatory authorities from
different countries
- Novel products are
developed, which include
- Modern biotechnology, which arose and was developed
through the 1970’s and 1980’s, has been normally
established as coming from industrialized countries.
- ECONOMIC IMPACT
- Intangible assets in sectors with a
potential in intellectual property
leads to the proposal of the design of a
strategy
- The intangible assets are a substantial
part of the economical benefits that a
biotech enterprise can receive, even
before a product is placed in the market
- Intangible assets in sectors with a
potential in intellectual property
leads to the proposal of the design of a
strategy
Möchten Sie kostenlos Ihre eigenen Mindmaps mit GoConqr erstellen? Mehr erfahren.